blah, blah blah, Berens hasn't been right on any of his "thesis" calls! What a joke..........MS you've lost credibility as an investment firm keeping this guy on your payroll!
with CRL of AZN's competing product, proposals have to be in the works for a buyout of RLYP.
They are on the wrong side and about to get toasted! ha ha!
when the news is great for RLYP.....hmm he must be short up to his aszz! lol
with hedge funds buying big stakes in RLYP he has to be really worried about a major short squeeze on takeover of RLYP!
it will bust right through it! watch and learn stupid shorts!
RLYP is ripe for the picking by big pharma now that AZN competing drug just failed miserably!
They need to decide and announce it!
the smell of fried shorts, love it! lol
stock is going to make a quick run and break 22 and its off to the races of buyout! Wouldn't be surprised if it happens this week! Merger mania is hitting biotechs
shorts are getting desperate here! lol
they know they ran out of "reasons" RLYP is going down
stock keeps moving up though....hmmm BO
once it breaks 22 soon it will start the big squeeze on shorts. Deerfield's buying over 5% will continue and they will publicly start pressure on management to start the negotiations to sell the company.
when the most ardent bear turns around and upgrades, that alone should point out that his thesis and sources are telling him that RLYP is going to win on this! The results from RLYP testing that shows its drug superior in use with chronic heart and kidney issues because of its lowering sodium levels is going to get big pharma jumping over each other to buy RLYP.
more testing will likely be required before FDA decided on chronic market. RLYP will fly on short squeeze and B.O. buyers will line up to grab RLYP. 50+
Do you really think 1.5 million fee is going to break a deal of 2 billion......come on that loan agreement is only a bargaining chip in getting the price RLYP wants.
25 to 30 in seconds